PADDI Trial reaches recruitment target
Congratulations to PADDI Trial for reaching the recruitment target of 8880 patients across 56 sites worldwide today, just over three years since the first patient was recruited https://www.researchpath.com.au/news/2016/03/10/paddi-trial-recruits-first-patient/.
The PADDI Trial has officially reached the recruitment target! Massive Congratulations to the team at St John of God Subiaco Hospital on randomising this final PADDI patient today. @Tomundoc @sjog_healthcare #anaesthesia #clinicaltrials pic.twitter.com/SFOa1cDXZu
— PADDI (@PADDI_Trial) July 29, 2019
Big congratulations to the whole PADDI team including investigators, staff, and committee members for achieving this milestone ahead of schedule. In particular Chief Investigator Dr Tomás Corcoran, Trial Manager Jaspreet Sidhu, and WA Trial Coordinator Pauline Coutts who have all done a fantastic job and been a pleasure to work alongside on this important research.
For more information on the trial see https://www.paddi.org.au/.
Research Path is a specialist in working with international randomised controlled trials. If you are running a relevant study please get in touch to see how we can support you - enquiries@researchpath.com.au.